Company News
Jefferies Holds Evonik, Targets €15.10, 12.6% Downside
Jefferies upgraded Evonik to “hold” from “underperform” and raised price target to €15.10, 12.6% below current €17.27 price.
FY26 EBITDA estimate lifted 3% to €1.86bn, FY27 trimmed to €1.85bn, both 4‑
